Compare Dyne Therapeutics Inc. Common Stock (DYN) vs Uber Technologies Inc (UBER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dyne Therapeutics Inc. Common Stock vs Uber Technologies Inc — how do they compare? Dyne Therapeutics Inc. Common Stock trades at $15.07 (market cap $2.86B), while Uber Technologies Inc trades at $69.01 (market cap $145.68B). The key difference: Uber Technologies Inc is far larger — about 50.9× Dyne Therapeutics Inc. Common Stock's market cap, and Uber Technologies Inc is more actively traded (12,849,263 versus 3,341,579). Which is the better fit depends on your goals — on Pluang, investors hold Dyne Therapeutics Inc. Common Stock for 0 Days and Uber Technologies Inc for 88 Days on average.
| DYN | UBER | |
|---|---|---|
Market Cap | $2.86B | $145.68B |
Volume | 3,341,579 | 12,849,263 |
Sector | Health | Technology |
52-Week High | $26.78 | $99.72 |
52-Week Low | $14.60 | $65.94 |
Typical Hold Time | 0 Days | 88 Days |
Enterprise Value | $2.18B | $155.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dyne Therapeutics (DYN) trades at $15.30, down 4.14% on the day, reflecting recent volatility amid mixed clinical trial news. The stock is in a neutral technical position with immediate support at $15 and resistance at $16. Fundamentally, the company is a clinical-stage biotech with no revenue, reporting a net loss of $446.21M in 2025, but maintains strong analyst support with an 85.7% buy rating and a $35.20 consensus price target. Recent news highlights progress in Phase 1/2 trials for neuromuscular diseases and a $375M public offering in July 2026 to fund development.
The investment case hinges on clinical success, offering significant upside to the price target, but carries high risk due to pre-revenue status, dependence on trial outcomes, and negative cash flow from operations. Investor sentiment is cautiously optimistic, buoyed by analyst confidence, though volatility from sector-specific news remains a near-term challenge.
Uber (UBER) trades at $71.5, showing minimal daily change. The stock exhibits a bullish technical signal overall, with strong fundamentals including a 19.3% net income margin and robust revenue growth to $52.0B in 2025. Recent news highlights expansion of the Uber Eats partnership with Costco to 47 states, enhancing delivery reach. Cash flow from operations remains strong at $10.1B, though 2026 projections indicate a net cash outflow. Analyst sentiment is overwhelmingly positive with an 82.5% buy rating and a consensus price target of $104.72.
The outlook for Uber is favorable, driven by strategic expansions and solid financial performance. Investment opportunities include market share gains in mobility and delivery, supported by high institutional confidence. Key risks involve competitive pressures in autonomous vehicles, execution of growth initiatives, and potential macroeconomic headwinds affecting consumer spending. The stock's current valuation metrics, such as a P/E of 15.6, suggest room for appreciation relative to analyst targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dyne Therapeutics Inc. Common Stock
Dyne Therapeutics, Inc. is a clinical-stage biotechnology company developing therapeutics for genetically driven neuromuscular diseases, including Duchenne muscular dystrophy and myotonic dystrophy type 1, with additional preclinical programs for facioscapulohumeral muscular dystrophy and Pompe disease.
Read more on DYN →About Uber Technologies Inc
Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food delivery service providers, and shippers with carriers. The firm's on-demand technology platform could eventually be used for additional products and services, such as autonomous vehicles, delivery via drones, and Uber Elevate, which, as the firm refers to it, provides aerial ride-sharing. Uber Technologies is headquartered in San Francisco and operates in over 63 countries with over 110 million users that order rides or foods at least once a month. Approximately 76% of its gross revenue comes from ride-sharing and 22% from food delivery.
Read more on UBER →
